2025-01-282026-01-312026-01-31false16213335Cormoran Medical Limited2026-03-30falseiso4217:GBPxbrli:pure162133352025-01-27162133352026-01-31162133352025-01-282026-01-31162133352025-01-26162133352025-01-27162133352025-01-272025-01-2716213335bus:SmallEntities2025-01-282026-01-3116213335bus:AuditExempt-NoAccountantsReport2025-01-282026-01-3116213335bus:AbridgedAccounts2025-01-282026-01-3116213335bus:PrivateLimitedCompanyLtd2025-01-282026-01-3116213335core:WithinOneYear2026-01-3116213335core:AfterOneYear2026-01-3116213335core:WithinOneYear2025-01-2716213335core:AfterOneYear2025-01-2716213335core:ShareCapital2026-01-3116213335core:SharePremium2026-01-3116213335core:RevaluationReserve2026-01-3116213335core:OtherReservesSubtotal2026-01-3116213335core:RetainedEarningsAccumulatedLosses2026-01-3116213335core:ShareCapital2025-01-2716213335core:SharePremium2025-01-2716213335core:RevaluationReserve2025-01-2716213335core:OtherReservesSubtotal2025-01-2716213335core:RetainedEarningsAccumulatedLosses2025-01-2716213335core:LandBuildings2026-01-3116213335core:PlantMachinery2026-01-3116213335core:Vehicles2026-01-3116213335core:FurnitureFittings2026-01-3116213335core:OfficeEquipment2026-01-3116213335core:NetGoodwill2026-01-3116213335core:IntangibleAssetsOtherThanGoodwill2026-01-3116213335core:ListedExchangeTraded2026-01-3116213335core:UnlistedNon-exchangeTraded2026-01-3116213335core:LandBuildings2025-01-2716213335core:PlantMachinery2025-01-2716213335core:Vehicles2025-01-2716213335core:FurnitureFittings2025-01-2716213335core:OfficeEquipment2025-01-2716213335core:NetGoodwill2025-01-2716213335core:IntangibleAssetsOtherThanGoodwill2025-01-2716213335core:ListedExchangeTraded2025-01-2716213335core:UnlistedNon-exchangeTraded2025-01-2716213335core:LandBuildings2025-01-282026-01-3116213335core:PlantMachinery2025-01-282026-01-3116213335core:Vehicles2025-01-282026-01-3116213335core:FurnitureFittings2025-01-282026-01-3116213335core:OfficeEquipment2025-01-282026-01-3116213335core:NetGoodwill2025-01-282026-01-3116213335core:IntangibleAssetsOtherThanGoodwill2025-01-282026-01-3116213335core:ListedExchangeTraded2025-01-282026-01-3116213335core:UnlistedNon-exchangeTraded2025-01-282026-01-3116213335core:MoreThanFiveYears2025-01-282026-01-3116213335core:Non-currentFinancialInstruments2026-01-3116213335core:Non-currentFinancialInstruments2025-01-2716213335dpl:CostSales2025-01-282026-01-3116213335dpl:DistributionCosts2025-01-282026-01-3116213335core:LandBuildings2025-01-282026-01-3116213335core:PlantMachinery2025-01-282026-01-3116213335core:Vehicles2025-01-282026-01-3116213335core:FurnitureFittings2025-01-282026-01-3116213335core:OfficeEquipment2025-01-282026-01-3116213335dpl:AdministrativeExpenses2025-01-282026-01-3116213335core:NetGoodwill2025-01-282026-01-3116213335core:IntangibleAssetsOtherThanGoodwill2025-01-282026-01-3116213335dpl:GroupUndertakings2025-01-282026-01-3116213335dpl:ParticipatingInterests2025-01-282026-01-3116213335dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-282026-01-3116213335core:ListedExchangeTraded2025-01-282026-01-3116213335dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-282026-01-3116213335core:UnlistedNon-exchangeTraded2025-01-282026-01-3116213335dpl:CostSales2025-01-272025-01-2716213335dpl:DistributionCosts2025-01-272025-01-2716213335core:LandBuildings2025-01-272025-01-2716213335core:PlantMachinery2025-01-272025-01-2716213335core:Vehicles2025-01-272025-01-2716213335core:FurnitureFittings2025-01-272025-01-2716213335core:OfficeEquipment2025-01-272025-01-2716213335dpl:AdministrativeExpenses2025-01-272025-01-2716213335core:NetGoodwill2025-01-272025-01-2716213335core:IntangibleAssetsOtherThanGoodwill2025-01-272025-01-2716213335dpl:GroupUndertakings2025-01-272025-01-2716213335dpl:ParticipatingInterests2025-01-272025-01-2716213335dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-272025-01-2716213335core:ListedExchangeTraded2025-01-272025-01-2716213335dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-272025-01-2716213335core:UnlistedNon-exchangeTraded2025-01-272025-01-2716213335core:NetGoodwill2026-01-3116213335core:IntangibleAssetsOtherThanGoodwill2026-01-3116213335core:LandBuildings2026-01-3116213335core:PlantMachinery2026-01-3116213335core:Vehicles2026-01-3116213335core:FurnitureFittings2026-01-3116213335core:OfficeEquipment2026-01-3116213335core:AfterOneYear2026-01-3116213335core:WithinOneYear2026-01-3116213335core:ListedExchangeTraded2026-01-3116213335core:UnlistedNon-exchangeTraded2026-01-3116213335core:ShareCapital2026-01-3116213335core:SharePremium2026-01-3116213335core:RevaluationReserve2026-01-3116213335core:OtherReservesSubtotal2026-01-3116213335core:RetainedEarningsAccumulatedLosses2026-01-3116213335core:NetGoodwill2025-01-2716213335core:IntangibleAssetsOtherThanGoodwill2025-01-2716213335core:LandBuildings2025-01-2716213335core:PlantMachinery2025-01-2716213335core:Vehicles2025-01-2716213335core:FurnitureFittings2025-01-2716213335core:OfficeEquipment2025-01-2716213335core:AfterOneYear2025-01-2716213335core:WithinOneYear2025-01-2716213335core:ListedExchangeTraded2025-01-2716213335core:UnlistedNon-exchangeTraded2025-01-2716213335core:ShareCapital2025-01-2716213335core:SharePremium2025-01-2716213335core:RevaluationReserve2025-01-2716213335core:OtherReservesSubtotal2025-01-2716213335core:RetainedEarningsAccumulatedLosses2025-01-2716213335core:NetGoodwill2025-01-2616213335core:IntangibleAssetsOtherThanGoodwill2025-01-2616213335core:LandBuildings2025-01-2616213335core:PlantMachinery2025-01-2616213335core:Vehicles2025-01-2616213335core:FurnitureFittings2025-01-2616213335core:OfficeEquipment2025-01-2616213335core:AfterOneYear2025-01-2616213335core:WithinOneYear2025-01-2616213335core:ListedExchangeTraded2025-01-2616213335core:UnlistedNon-exchangeTraded2025-01-2616213335core:ShareCapital2025-01-2616213335core:SharePremium2025-01-2616213335core:RevaluationReserve2025-01-2616213335core:OtherReservesSubtotal2025-01-2616213335core:RetainedEarningsAccumulatedLosses2025-01-2616213335core:AfterOneYear2025-01-282026-01-3116213335core:WithinOneYear2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:CostValuation2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-282026-01-3116213335core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3116213335core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-3116213335core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3116213335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-3116213335core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-3116213335core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-3116213335core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-3116213335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-3116213335core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-3116213335core:Non-currentFinancialInstrumentscore:CostValuation2025-01-2716213335core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-2716213335core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-2716213335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-2716213335core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-2716213335core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-2716213335core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-2716213335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-2716213335core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-2716213335bus:Director12025-01-282026-01-3116213335bus:Director22025-01-282026-01-31

Cormoran Medical Limited

Registered Number
16213335
(England and Wales)

Unaudited Financial Statements for the Period ended
31 January 2026

Cormoran Medical Limited
Company Information
for the period from 28 January 2025 to 31 January 2026

Directors

Coulson, Christopher John
Coulson, Hannah Louise

Registered Address

White Horse
Binton
Stratford-Upon-Avon
CV37 9TW

Registered Number

16213335 (England and Wales)
Cormoran Medical Limited
Balance Sheet as at
31 January 2026

Notes

2026

£

£

Current assets
Debtors576
Cash at bank and on hand16,744
17,320
Creditors amounts falling due within one year(5,018)
Net current assets (liabilities)12,302
Total assets less current liabilities12,302
Net assets12,302
Capital and reserves
Called up share capital1
Profit and loss account12,301
Shareholders' funds12,302
The financial statements were approved and authorised for issue by the Board of Directors on 30 March 2026, and are signed on its behalf by:
Coulson, Christopher John
Director
Coulson, Hannah Louise
Director

Registered Company No. 16213335
Cormoran Medical Limited
Notes to the Financial Statements
for the period ended 31 January 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

2026
Average number of employees during the year2